VR Logo

RxSight Inc. (RXST) download report


Healthcare | Medical Devices & Equipment

RxSight Inc. (RXST) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally.

IPO Date: 30-Jul-2021

Pres, CEO & Director: Dr. Ronald M. Kurtz M.D.

CFO & Assistant Sec.: Ms. Shelley B. Thunen

Listing: NASDAQ: RXST

Country: United States

Headquarters: Aliso Viejo, CA

Website: https://www.rxsight.com

Key Facts

Market cap: $417.53 Mln

Revenue (TTM): $28.05 Mln

Earnings (TTM): $-59.48 Mln

Cash: $143.85 Mln

Total Debt: $44.90 Mln

Insider's Holding: 21.73%

Liquidity: Low

52 Week range: $8.80 - 19.67

Shares outstanding: 27,505,100

Stock Performance

Time Period RxSight (RXST) S&P BSE Sensex S&P Small-Cap 600
YTD24.62-8.79-19.61
1 month-12.38-4.72-9.38
3 months10.66-12.34-15.04
1 Year--1.24-17.73
3 Years--10.015.82
5 Years--11.235.47
10 Years--11.779.50
As on 05-Jul-2022